PR PolyResearch

Join Free

NASDAQ

NexGel, Inc (NXGL)

♥ 544 Thanks from members

NexGel, Inc (NXGL) faces severe going-concern warnings, widening net losses, and microcap distressed valuation pressures following the Celularity asset acquisition, offset by modest revenue growth in new BioNX biomaterials.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)